AFAndrew Ford

Andrew Ford

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew Ford has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnostic Evaluation of Seronegative Celiac Disease

    by Andrew Ford, Claire Jansson-Knodell, Alberto Rubio-Tapia

  • Effect of Interfacility Transfer on Outcomes in Pediatric Severe Traumatic Brain Injury Patients

    by Sanjan Kumar, Philip Lee, Brian Chin, Hazem Nasef, Zackary Yates, Andrew Ford, Ian Bundschu, Donald Plumley, Adel Elkbuli

    Background/Rationale: Existing literature on pediatric traumatic brain injury (TBI) transfers to higher-level trauma centers is limited. Most studies focus on inhospital mortality and neurosurgical intervention rates, often overlooking outcomes such as early discharge without neurosurgical intervention, intensive care unit length of stay, and discharge disposition. Objectives: To assess the impact of transfer to a higher-level trauma center on clinical outcomes of pediatric severe TBI patients. Methods: This retrospective cohort study used the American College of Surgeons Trauma Quality Improvement Program database between 2017 and 2023 to evaluate pediatric trauma patients with isolated severe TBI transferred from lower-level to higher-level trauma centers. The primary outcome was the odds of discharge within 24 or 48 h without requiring neurosurgical intervention and rates of neurosurgical intervention. Secondary outcomes included emergency department and 24-h mortality, initial and repeat computerized tomography scan rates, intensive care unit length of stay, ventilator-free days, and discharge home. Results: Of the 4,154 pediatric patients with isolated severe TBI, 1,723 (41.5%) were transferred, and 2,418 (58.2%) were not. Transferred patients had a 42% lower odds of discharge within 24 h without neurosurgical intervention (OR: 0.58, 95% CI [0.41, 0.80], p < .001), were more likely to undergo neurosurgical intervention (OR: 1.26, 95% CI [1.04, 1.53], p = .016), and were more likely to be discharged home (OR: 1.58, 95% CI [1.30, 1.92], p < .001). Mortality rates did not differ significantly between groups. Conclusion: Transfer to higher-level trauma centers is associated with increased neurosurgical intervention and higher rates of discharge home in pediatric patients with severe TBI, without differences in mortality.


  • Timing of Extracorporeal Membrane Oxygenation and Outcomes in Adult Patients With Moderate-Severe Blunt Thoracic Trauma

    by Philip Lee, Nikita Nunes, Andrew Ford, Ruth Zagales, Zackary Yates, Kirk Dourvetakis, Nickolas Hernandez, Chadwick P. Smith, Adel Elkbuli

    Background: There is mixed evidence on the optimal timing of veno-venous extracorporeal membrane oxygenation (VV-ECMO) following significant trauma. Objective: This study aims to assess the timing of VV-ECMO initiation and its effect on clinical outcomes in adult patients with moderate-severe blunt thoracic trauma. Methods: This retrospective cohort study utilized the American College of Surgeons Trauma Quality Improvement Program Participant Use File (ACS-TQIP-PUF) database between 2015 and 2023 to evaluate the clinical effects of VV-ECMO in adult patients (≥18 years) with blunt, moderate-severe thoracic and thoraco-abdominal trauma. Outcomes of interest included in-hospital mortality, intensive care unit length of stay (ICU-LOS), complications such as deep vein thrombosis, pulmonary embolism, acute kidney injury, and discharge disposition. Results: There were 412 adult patients with moderate-severe blunt thoracic and thoraco-abdominal trauma who received VV-ECMO, of which 256 (61.8%) were initiated within ≤7 days and 105 (25.4%) after 7 days. Patients with VV-ECMO initiation within ≤7 days had no difference in mortality rates (adjusted odds ratio [aOR] .655, p = .246) but had five fewer ICU-LOS days (β: −5.364, p = .002). Additionally, patients receiving early VV-ECMO were less likely to be discharged home (aOR: .192, p = .017) than all other discharge dispositions. No differences were observed in transfusion needs or complication rates. Conclusion: Initiation of VV-ECMO within ≤7 days was associated with significantly shorter ICU-LOS and comparable odds of mortality, without significant differences in complications or adverse events, including transfusion requirements and venous thromboembolism. Trauma and critical care societies should consider these findings when revisiting existing ECMO protocols concerning the early initiation of VV-ECMO to improve outcomes in this population.

  • Fatty Pancreas Disease and the Risk of Future Diseases of the Exocrine Pancreas: A US Matched Cohort Study

    by Arjun Chatterjee, Amandeep Singh, Raj Jessica Thomas, Renan Prado, Ridhima Kaul, Andrew Ford, Rupayan Kundu, Huijun Xiao, Qijun Yang, John McMichael, et al.

    INTRODUCTION: Fatty pancreas disease (FPD), marked by excess fat within the pancreas, is often incidentally detected on imaging. Despite recognized metabolic links, its clinical significance remains unclear. More granular data from large, well-characterized US cohorts are needed to clarify its relevance. This study quantified intrapancreatic fat deposition and assess its natural history and related outcomes. METHODS: Adults 18 years and older with radiologically confirmed FPD between 2004 and 2024 were identified from institutional databases. Controls without FPD were matched 1:2 by age, sex, body mass index, and smoking status. Patients with excessive alcohol intake, previous pancreatitis, pancreatic cancer, surgery, cystic fibrosis, or prolonged steroid/antiviral use were excluded. Fat content in the pancreas and liver, as well as subcutaneous and visceral fat areas, were measured using iNtuition software on noncontrast computed tomography scans. RESULTS: We included 82 FPD patients and 164 matched controls (median age 65 years; 55% women; median body mass index 32). Subcutaneous and hepatic fat were similar between groups, but intrapancreatic fat deposition was markedly higher in FPD patients (26.8% vs 4.9%, P < 0.001). Over a mean 4-year follow-up, FPD patients had significantly higher rates of acute pancreatitis (12% vs 1.2%, P < 0.001), chronic pancreatitis (6.1% vs 0.6%, P = 0.017), pancreatic cysts (34.1% vs 4.9%, P < 0.001), and pancreatic cancer (1.6% vs 0%, P = 0.012). Extrapancreatic cancer incidence did not differ. DISCUSSION: FPD is associated with an increased risk of pancreatic cancer, acute pancreatitis, chronic pancreatitis, and incidental pancreatic cysts, independent of obesity or hepatic steatosis, suggesting a potentially causative role of FPD in the pathogenesis of exocrine pancreatic diseases.


  • Delirium in Critically Ill Geriatric Surgical Patients: A Systematic Review of Screening, Risk Factors, Diagnosis, and Management

    by Zackary Bs Yates, Philip Bs Lee, Nikita Nunes Espat, Ruth Bs Zagales, Nickolas Bs Hernandez, Quratulain Bs Amin, Andrew Bs Ford, Caitlin Tweedie, Adel Md Elkbuli

    OBJECTIVE: This systematic review aims to evaluate optimal early screening strategies, significant risk factors, and effective diagnostic and management approaches for delirium in critically ill geriatric surgical patients. DATA SOURCES: A comprehensive search was conducted across five databases: PubMed, Google Scholar, ProQuest, Embase, and Cochrane. STUDY SELECTION: Studies were included based on their relevance to early screening, risk factors, diagnostic accuracy, and management strategies for delirium in critically ill geriatric surgical patients. The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. DATA EXTRACTION: A total of 31 studies met the inclusion criteria. Outcomes of interest included effective early screening/prevention strategies, significant risk factors, sensitive diagnosis tools, and effective management strategies. DATA SYNTHESIS: Early screening strategies, including advanced neural networks and E-PROD-NS, demonstrated high sensitivity and specificity (area under the receiver operating characteristic curve >0.76). Key risk factors included advanced age, renal dysfunction, cognitive impairment, prolonged intensive care unit length of stay (ICU-LOS), and mechanical ventilation time. Diagnostic tools such as the 4A’s test and serum biomarkers exhibited superior accuracy compared to the ICU Confusion Assessment Method and Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria. Management strategies effectively reduced delirium duration, including acetaminophen, environmental modifications, and family involvement. CONCLUSIONS: E-PROD-NS and the 4A’s test were associated with early delirium detection and intervention. Risk factors for delirium included advanced age, renal dysfunction, and existing cognitive dysfunction. Mitigating mechanical ventilation and ICU-LOS duration, treatment with acetaminophen, and environmental modifications reduced delirium duration in critically ill geriatric surgical patients. REGISTRATION: PROSPERO #CRD42025632279.


  • Open Access

    Combined Heart-Liver Transplant vs. Heart Transplant Alone: A Single Center Experience

    by Ritika Mazumder, Andrew Ford, Omar T. Sims, Jamak Modaresi Esfeh

    Combined heart-liver transplantation (CHLT) is a viable option for concurrent heart and liver failure, yet its indications are unclear. This preliminary study aimed to describe pre-transplant characteristics and outcomes of patients with liver fibrosis undergoing HT and CHLT, while exploring decompensated liver dysfunction following HT. A total of 52 patients (HT = 42; CHLT = 10) were included. In HT patients, F1 fibrosis was more common (52%), with 43% exhibiting F3 or F4 fibrosis. F4 fibrosis was predominant in the CHLT patients (80%). Post-hepatic portal hypertension was present in 62% of HT and 90% of CHLT patients. None progressed to liver decompensation (i.e., new ascites, variceal bleed, jaundice, hepatic hydrothorax, or hepatic encephalopathy) after HT. Over a median follow-up period of 3.7 [IQR 1.2–9.1] years, the two groups did not differ statistically in survival (p = 0.60). Altogether, HT and CHLT may have similar survival outcomes, and HT patients may not progress to decompensation postoperatively despite advanced fibrosis. Decompensated cirrhosis could serve as a factor for identifying CHLT candidates, but it is crucial to differentiate it from post-hepatic portal hypertension, which does not necessitate liver transplant. Further research is needed to determine selection criteria for CHLT, ensuring efficient utility of organs.


  • Open Access

    Prevalence Rates of Pneumococcal Vaccination in IBD and 30-Day Clinical Outcomes in Patients With IBD and Pneumococcal Disease Stratified by Receipt of Pneumococcal Vaccination: A Multi-Network Study

    by Andrew Ford, Vibhu Chittajallu, Jaime Abraham Perez, Scott Martin, Motasem Alkhayyat, Maneesh Dave, Edith Y Ho, Preetika Sinh, Vu Nguyen, Gregory Cooper, et al.

    Lay Summary: This study sought to assess outcomes associated with pneumococcal vaccination in adult inflammatory bowel disease patients. Results found unvaccinated patients had higher adverse outcomes, including greater risk of hospitalization, ICU admission, ventilation, and mortality. These findings underscore the importance of pneumococcal vaccination.


  • Mo1017 HEALTH DISPARITY IN CELIAC DISEASE TESTING: SEROLOGY OCCURS LESS FREQUENTLY IN MEN AND AFRICAN AMERICAN PATIENTS WITH VILLOUS ATROPHY

    by Andrew M. Ford, Chiara Maruggi, Paige Gurizzian, Arjun Chatterjee, Claire Jansson-Knodell, Alberto Rubio-Tapia